Natriuretic Peptide and Cardiovascular Risk: Is It About “U”?
Main Authors: | Christopher R. deFilippi, Stephen L. Seliger |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-05-01
|
Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Subjects: | |
Online Access: | https://doi.org/10.1161/JAHA.115.002086 |
Similar Items
-
The Prognostic Value of Natriuretic Peptides in Stable Patients with Suspected Acute Myocarditis: A Retrospective Study
by: Gassan Moady, et al.
Published: (2022-04-01) -
Risk Estimates of Imminent Cardiovascular Death and Heart Failure Hospitalization Are Improved Using Serial Natriuretic Peptide Measurements in Patients With Coronary Artery Disease and Type 2 Diabetes
by: Emil Wolsk, et al.
Published: (2022-04-01) -
Associations of atrial natriuretic peptide with measures of insulin and adipose depots
by: Catharine A. Couch, et al.
Published: (2023-03-01) -
Natriuretic peptides and their usefulness in clinical practise
by: Aleksandra Skałecka, et al.
Published: (2020-09-01) -
Racial Differences in Circulating Natriuretic Peptide Levels: The Atherosclerosis Risk in Communities Study
by: Deepak K. Gupta, et al.
Published: (2015-05-01)